HYFT NASDAQ Week ended 24 Jul 2026

Weekly Investor Report

ImmunoPrecise Antibodies Ltd. · Healthcare · Biotechnology

Open interactive chart View report data
Latest close 1.36 USD
-6.8% latest week
Weekly setup

Weak trend

The weekly trend is not active. Price is -8.8% below the Trend Line and sits at 16.4% of its 52-week range. The latest completed week returned -6.8%, after a -13.9% four-week move. The latest factor snapshot indicates quality ranks weakly versus its universe; growth ranks weakly; valuation is expensive relative to peers. Options positioning is volatility with 46/100 conviction, while the latest news-sentiment score is 57/100. Near-term considerations: earnings are due in 4d.

Setup score 28 out of 100
Latest Close 1.36 USD 24 Jul 2026
1W Return -6.8% latest completed week
4W Return -13.9% short-term follow-through
12W Return 12.4% quarterly tape
Trend Breadth 50.0% 26 of 52 weeks active
Volume Ratio 1.3x vs 13-week average
What is working
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Next-week expectancy is negative at 40.62% based on similar historical setup states.
  • Activity pressure is weak, so confirmation is not yet broad enough.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through -6.8% Latest completed week; four-week move -13.9%. Indicator stack 28/50 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Negative 40.62% Historical one-week expectancy contributes to the evidence score when direction is confirmed. Options pressure Volatility 46/100 conviction; expected move 82.7%. News sentiment 57/100 26 relevant articles in the latest sentiment read. Event risk 4d Next report is scheduled for 04 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is -8.8% below the Trend Line and sits at 16.4% of its 52-week range. The latest completed week returned -6.8%, after a -13.9% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.3x the 13-week average. Participation is around or above normal and provides reasonable confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
30 Jan 6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.2912-week average 0.17

12-week confirmation

Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure9/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.29Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -13.9% over four weeks, 12.4% over 12 weeks, and -37.0% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W-6.8%
4W-13.9%
12W12.4%
26W-40.1%
52W-37.0%
Active trend streak0 weeks
Active weeks in one year26
Trend breadth50.0%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.29Latest activity-pressure read.
Pressure change-60.1%Four-week change in activity pressure.
Leadership-25.65Latest relative-leadership reading.
RS change-38.5%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks weakly versus its universe; growth ranks weakly; valuation is expensive relative to peers.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 30 Apr 2026 Field coverage 82% Model confidence 82%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength3/100Blend of value, momentum, and quality. Underlying universe rank 98; rank 1 is best.
Value20/100Relative valuation strength. Underlying universe rank 81; rank 1 is best.
Quality8/100Profitability and accounting quality. Underlying universe rank 93; rank 1 is best.
Momentum10/100Medium-term price momentum. Underlying universe rank 91; rank 1 is best.
Growth16/100Revenue and earnings growth. Underlying universe rank 85; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
-
Price divided by trailing earnings.
Price / sales
4.1x
Market value relative to trailing revenue.
EV / EBITDA
-
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
-21.7%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
58.8%
Gross profit retained from each unit of revenue.
Operating margin
-100.6%
Operating profit retained from revenue.
Free-cash-flow margin
-78.4%
Free cash flow generated from revenue.
Return on invested capital
-297.5%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
-15.5%
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-
Latest one-year free-cash-flow growth.
Piotroski F-score
5/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
0.0%
Net share repurchases relative to market value.
Shareholder yield
0.0%
Dividend yield plus net buyback yield.
Net debt / EBITDA
0.6x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningVolatility

HYFT shows volatility options pressure with a 46/100 conviction score, put-call volume ratio of 0.17, expected move of 82.7%, and Sharemaestro trend signal inactive.

Conviction46/100
Expected move82.7%
Put/call volume0.17
Pressure82
Speculation9
Volatility96
Trend agreement0
Open options detail
Insider activity-

No recent insider transactions are stored for this company.

News sentiment57/100

Weighted news tone is neutral across 26 relevant articles.

7 positive · 18 neutral · 1 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings4dNext report is scheduled for 04 Aug 2026; event risk rises as the date approaches.
Options expected move82.7%Nearest-chain priced movement where available.
52-week drawdown-58.1%Distance below the 52-week high.
13-week volatility12.9%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher8 of 2618 weeks finished lower.
Best week+43.7%Week of 22 May.
Worst week-28.6%Week of 30 Jan.
Latest week-6.8%Week of 24 Jul.

Shape of recent returns

Strong gains5
Modest gains3
Flat weeks0
Modest losses5
Sharp losses13
Recent vol12.9%13-week weekly-return volatility.
Base vol16.5%52-week weekly-return volatility.
Up/down split20/31Count of positive and negative weeks in the 52-week window.
Average skew15.6% / -9.5%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape28/100

Trend, activity pressure, participation, and risk combine to a 28/100 tape read.

 Indicator analysis29/100

Latest 12-week confirmation: trend 0/12, activity pressure 9/12, relative leadership 0/12.

Activity pressure 0.29; No reversal markers Next-Week ExpectancyNegative 40.62%

Next-week expectancy is negative with a 40.62% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors9/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 57; Small Cap Core rank 80 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Options34/100

HYFT shows volatility options pressure with a 46/100 conviction score, put-call volume ratio of 0.17, expected move of 82.7%, and Sharemaestro trend signal inactive.

Volatility · Volatility expansion watch · Expected move 82.7% Sentiment57/100

Weighted news tone is neutral across 26 relevant articles.

MindWalk Holdings (Nasdaq: HYFT) readies $250M shelf for AI-driven growth Insiders50/100

No recent insider transaction evidence is stored.

 Earnings4d

Next report is scheduled for 04 Aug 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
24 Jul 20261.36 USD-6.8%1.49 USD1.27 USD0.29-25.652.3MOff
17 Jul 20261.46 USD2.1%1.50 USD1.28 USD0.43-22.49888.6KOff
10 Jul 20261.43 USD-8.9%1.51 USD1.29 USD0.49-27.751.1MOff
3 Jul 20261.57 USD-0.6%1.52 USD1.30 USD0.63-19.641.2MOff
26 Jun 20261.58 USD3.3%1.54 USD1.31 USD0.73-18.521.6MOff
19 Jun 20261.53 USD-1.9%1.55 USD1.31 USD0.80-24.541.0MOff
12 Jun 20261.56 USD-7.1%1.56 USD1.32 USD0.95-20.922.2MOff
5 Jun 20261.68 USD-4.5%1.56 USD1.33 USD0.67-12.372.5MOff
29 May 20261.76 USD2.9%1.56 USD1.34 USD0.32-11.631.9MOff
22 May 20261.71 USD43.7%1.57 USD1.35 USD-0.19-10.845.6MOff
15 May 20261.19 USD-6.3%1.56 USD1.36 USD-0.74-36.62778.0KOff
8 May 20261.27 USD5.0%1.58 USD1.37 USD-0.93-32.22734.1KOff
1 May 20261.21 USD-0.8%1.59 USD1.39 USD-1.12-31.44703.1KOff
24 Apr 20261.22 USD-8.3%1.61 USD1.40 USD-1.14-29.36708.5KOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.